Next-Gen Genotyping (NGG)
Plant Science
Applications in AgBio, plant biology and biofuel production enable flexible exploration of plant genetics and relevance in commercial markets
Applications in AgBio, plant biology and biofuel production enable flexible exploration of plant genetics and relevance in commercial markets
From optimizing traits in commercial agricultural crops to understanding plant biology, genetics and genetic testing play an integral role in characterizing key regulatory elements. The genetic testing options for plant science have traditionally been extremely limited in scope and prohibitively expensive, compromising the ability for routine or en mass genotyping of plants. As such, a new technology is desperately needed to allow broad genotyping of low density markers for a significantly reduced cost.
Addressing genetic testing needs for plant research, the NGG has broad application in AgBio and other plant research projects. The assay offers low-cost, high value testing for traits such as yield, environmental resilience and nutritional value for any plant species of interest, including tetraploid species. Eureka Genomics is developing a commercial panel for comprehensive screening of barley in conjunction with the James Hutton Institute and will be broadening the scope of the NGG portfolio for plant science.
Eureka Genomics’ next-gen genotyping (NGG) provide an improved and economical alternative to traditional technologies for profiling hundreds of SNPs (or other genetic markers) in hundreds to thousands of samples using Next Generation Sequencing (NGS). The assay can be broadly applied to the detection of SNPs, InDels, CNV and methylation and is compatible with DNA or RNA from virtually any organism, even when genome information may be incomplete. The NGG provides rapid, accurate, cost-effective answers by combining discriminatory power of hybridization and ligation, focused high throughput sequencing and rigorously designed statistical analysis.
Eureka Genomics offers access to NGG as either standard or custom designed panels and testing can be performed either as a service through our expert scientific team or in your own lab (with technical support from EG to get you started). The assay is sequencing instrument agnostic, so regardless of the platform you have invested resources into or upgrade to in the future the NGG can be adapted to ensure easy assimilation and rapid data generation for your research or clinical goals. And because NGS is used to provide focused information on only the sequences of interest (and not the rest of the genome), the cost per genotype is extremely low.